BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) has announced the resignation of David Ryan from its Board of Directors. This move is part of the company's efforts to meet Nasdaq requirements for a majority of independent directors, as BioHarvest prepares to apply for listing on the Nasdaq Stock Market.
Despite stepping down from the board, Mr. Ryan will continue to play a important role in the company's management as Vice President of Investor Relations. Board Chair Zaki Rakib expressed gratitude for Ryan's directorship, which has been instrumental in the company's development, and acknowledged his ongoing support and commitment to BioHarvest's mission.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ha annunciato le dimenisoni di David Ryan dal suo Consiglio di Amministrazione. Questa decisione fa parte degli sforzi dell'azienda per soddisfare i requisiti del Nasdaq riguardo a un consiglio di amministrazione composto per la maggior parte da membri indipendenti, mentre BioHarvest si prepara a fare domanda per la quotazione nel mercato azionario Nasdaq.
Nonostante le dimissioni dal consiglio, il Sig. Ryan continuerà a ricoprire un ruolo importante nella gestione dell'azienda come Vicepresidente delle Relazioni con gli Investitori. Il Presidente del Consiglio Zaki Rakib ha espresso gratitudine per la direzione di Ryan, che è stata fondamentale nello sviluppo dell'azienda, e ha riconosciuto il suo continuo supporto e impegno per la missione di BioHarvest.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ha anunciado la renuncia de David Ryan a su Junta Directiva. Este movimiento es parte de los esfuerzos de la empresa para cumplir con los requisitos de Nasdaq para la mayoría de directores independientes, mientras BioHarvest se prepara para solicitar su cotización en el mercado de valores Nasdaq.
A pesar de dejar la junta, el Sr. Ryan continuará desempeñando un papel importante en la gestión de la empresa como Vicepresidente de Relaciones con Inversores. El Presidente de la Junta, Zaki Rakib, expresó su gratitud por la dirección de Ryan, que ha sido instrumental en el desarrollo de la empresa, y reconoció su apoyo y compromiso continuo con la misión de BioHarvest.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)는 데이비드 라이언의 이사회 사임을 발표했습니다. 이 결정은 나스닥 상장 요건을 충족하기 위한 회사의 노력의 일환으로, BioHarvest가 나스닥 주식 시장에 상장 신청을 준비하고 있습니다.
이사회에서 물러나긴 했지만, 라이언 씨는 투자자 관계 부사장으로서 회사 관리에서 중요한 역할을 계속할 것입니다. 이사회 의장인 자키 라킵은 라이언의 이사직에 대해 감사의 말을 전하며, 그의 지원이 회사 발전에 결정적이었다고 인정하고 BioHarvest의 사명에 대한 그의 지속적인 지원과 헌신을 강조했습니다.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) a annoncé la démission de David Ryan de son Conseil d'Administration. Ce mouvement s'inscrit dans les efforts de l'entreprise pour répondre aux exigences du Nasdaq concernant une majorité de directeurs indépendants, alors que BioHarvest se prépare à demander une cotation sur le marché boursier Nasdaq.
Malgré sa démission du conseil, M. Ryan continuera à jouer un rôle important dans la gestion de l'entreprise en tant que Vice-Président des Relations Investisseurs. Le Président du Conseil, Zaki Rakib, a exprimé sa gratitude pour le mandat de Ryan, qui a été déterminant dans le développement de l'entreprise, et a reconnu son soutien continu et son engagement envers la mission de BioHarvest.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) hat den Rücktritt von David Ryan aus dem Vorstand bekannt gegeben. Dieser Schritt ist Teil der Bemühungen des Unternehmens, die Anforderungen von Nasdaq zu erfüllen, die eine Mehrheit unabhängiger Direktoren erfordern, während BioHarvest sich auf die Beantragung einer Börsennotierung an der Nasdaq vorbereitet.
Obwohl er aus dem Vorstand ausscheidet, wird Herr Ryan weiterhin eine wichtige Rolle im Management des Unternehmens als Vizepräsident für Investorenbeziehungen spielen. Der Vorstandsvorsitzende Zaki Rakib drückte seine Dankbarkeit für Ryans Direktorenarbeit aus, die für die Entwicklung des Unternehmens entscheidend war, und erkannte seine fortlaufende Unterstützung und sein Engagement für die Mission von BioHarvest an.
- Preparation for potential Nasdaq listing, indicating potential growth and increased visibility
- Retention of David Ryan in a key management role as VP of Investor Relations
- Compliance with Nasdaq's independent director requirements
- None.
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company's management team, continuing to serve as Vice President of Investor Relations of the Company.
Mr. Ryan resigned as a director of the Company in order for the Company to meet Nasdaq mandates to have a majority of independent directors in connection with its proposed application to list its common shares on the Nasdaq Stock Market.
"On behalf of the Board, we extend our deepest gratitude to David Ryan for his directorship which has been foundational to the development of the Company," said Zaki Rakib, Board Chair. "His cooperation is a testimony of his continued support and devotion to the Company's mission and belief."
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/223978
FAQ
Why did David Ryan resign from BioHarvest Sciences' Board of Directors?
Will David Ryan continue to work with BioHarvest Sciences after his resignation?
What is BioHarvest Sciences' plan regarding Nasdaq listing?
How did the Board of BioHarvest Sciences react to David Ryan's resignation?
